Ease restrictions on U.S. blood donations


Unnecessary restrictions on blood donors should be removed to maximize the blood and plasma available for use. With a vaccine for coronavirus disease 2019 (COVID-19) likely more than a year away, we must identify effective therapies for patients now. One promising approach is the use of plasma from patients who have recovered from COVID-19 (1, 2). To facilitate this strategy, the U.S. Food and Drug Administration (FDA) recently revised some of the restrictions on blood donation, including a decrease in deferral time for men who have sex with men (MSM) to 3 months (3). This is a positive change to an outdated guideline, but it does not go far enough.

Duplicate Docs Excel Report

None found

Similar Docs  Excel Report  more

None found